138 related articles for article (PubMed ID: 34325761)
1. Association between
Evans ME; McCauley BP; Simbartl LA
Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1940-1941. PubMed ID: 34325761
[TBL] [Abstract][Full Text] [Related]
2. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
Miller R; Morillas JA; Brizendine KD; Fraser TG
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
[TBL] [Abstract][Full Text] [Related]
4. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
Humphries RM; Uslan DZ; Rubin Z
J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
[TBL] [Abstract][Full Text] [Related]
5. Real-world evaluation of a two-step testing algorithm for
Hecker MT; Son AH; Zuccaro P; Conti J; Donskey CJ
Infect Control Hosp Epidemiol; 2023 Sep; 44(9):1494-1496. PubMed ID: 36750229
[TBL] [Abstract][Full Text] [Related]
6. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
[TBL] [Abstract][Full Text] [Related]
7. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
[TBL] [Abstract][Full Text] [Related]
9. Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes.
Hitchcock MM; Holubar M; Hogan CA; Tompkins LS; Banaei N
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31511334
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
[TBL] [Abstract][Full Text] [Related]
11. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.
Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA
Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711
[TBL] [Abstract][Full Text] [Related]
12. Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset
McCormick WL; Jackson G; Andrea SB; Whitehead V; Chargualaf TL; Touzard-Romo F
Infect Control Hosp Epidemiol; 2024 Jan; 45(1):106-109. PubMed ID: 37424227
[TBL] [Abstract][Full Text] [Related]
13. Discordant
Lenggenhager L; Zanella MC; Poncet A; Kaiser L; Schrenzel J
BMJ Open; 2020 Sep; 10(9):e036342. PubMed ID: 32928850
[TBL] [Abstract][Full Text] [Related]
14. Latent Class Analysis for the Diagnosis of Clostridioides difficile Infection.
Doolan CP; Louie T; Lata C; Larios OE; Stokes W; Kim J; Brown K; Beck P; Deardon R; Pillai DR
Clin Infect Dis; 2021 Nov; 73(9):e2673-e2679. PubMed ID: 33053174
[TBL] [Abstract][Full Text] [Related]
15. Sequential introduction of a multistep testing algorithm and nucleic acid amplification testing leading to an increase in
Skinner AM; Yu B; Cheknis A; Pacheco SM; Gerding DN; Johnson S
Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1148-1153. PubMed ID: 32576334
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of a newly developed high-speed polymerase chain reaction analysis system for the diagnosis of Clostridioides difficile infection.
Furukawa K; Mitsutake H; Aso R; Sekizawa R; Okanda T; Hayashi K; Matsumoto T; Nakamura S
J Infect Chemother; 2021 May; 27(5):715-721. PubMed ID: 33402305
[TBL] [Abstract][Full Text] [Related]
17. Potential underreporting of treated patients using a
Guh AY; Fridkin S; Goodenough D; Winston LG; Johnston H; Basiliere E; Olson D; Wilson CD; Watkins JJ; Korhonen L; Gerding DN
Infect Control Hosp Epidemiol; 2024 May; 45(5):590-598. PubMed ID: 38268440
[TBL] [Abstract][Full Text] [Related]
18. Effect of testing methods on incidence of
McCauley BP; Evans ME; Simbartl LA; Gamage SD; Kralovic SM; Roselle GA
Infect Control Hosp Epidemiol; 2021 Apr; 42(4):461-463. PubMed ID: 33185177
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection.
Bruins MJ; Verbeek E; Wallinga JA; Bruijnesteijn van Coppenraet LE; Kuijper EJ; Bloembergen P
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3035-9. PubMed ID: 22706512
[TBL] [Abstract][Full Text] [Related]
20. Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device.
Okanda T; Mitsutake H; Aso R; Sekizawa R; Takemura H; Matsumoto T; Nakamura S
Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115247. PubMed ID: 33188946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
